The recommendations for hospitalized children with MIS-C include:
- Use of corticosteroids in addition to supportive care (rather than either intravenous immunoglobulin plus supportive care, or supportive care alone), for hospitalized children aged 0-18 years old who meet a standard case definition for MIS-C.
- Use of corticosteroids in addition to standard of care for hospitalized children aged 0-18 years who meet both a standard case definition for MIS-C and diagnostic criteria for Kawasaki disease.
The updated guidance is part of the WHO’s COVID-19 resource, Clinical management: living guidance, which contains the organization’s most up-to-date recommendations for the clinical management of COVID-19 patients.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
